Retraction notices

Development of a highly sensitive chemiluminescence immunoassay using a novel signal-enhanced detection system for quantitation of durvalumab, an immune-checkpoint inhibitor monoclonal antibody used for immunotherapy of lung cancer

Type
Retraction
Notice date
11/13/2023 0:00
Journal
Heliyon
Publisher
Elsevier - Cell Press
Notice DOI
10.1016/j.heliyon.2023.e22374
Original paper DOI
10.1016/j.heliyon.2023.e15782

Reasons

Matching venue names

Name match only, not an authoritative journal identifier.